Stockscreener 앱 받기
11.98
2.57%
0.30
시간 외 거래:
11.75
-0.23
-1.92%
Elicio Therapeutics Inc 주식(ELTX)의 최신 뉴스
Wall Street Analysts Predict a 42.28% Upside in Elicio Therapeutics (ELTX): Here's What You Should Know - Yahoo Finance
Valuation Update: Can Elicio Therapeutics Inc benefit from deglobalization2026 Stock Rankings & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Elicio Therapeutics reports inducement grants - TipRanks
Biotech new hire lands 1,600 stock options at Elicio Therapeutics - Stock Titan
Rodman & Renshaw initiates coverage of Elicio Therapeutics (ELTX) with buy recommendation - MSN
[EFFECT] Elicio Therapeutics, Inc. SEC Filing - Stock Titan
Elicio Therapeutics Reports Inducement Grants - Bitget
Elicio Therapeutics, Inc. Enters At Market Issuance Sales Agreement for Up to $400 Million with Nasdaq Listing - Minichart
Elicio Therapeutics launches new $100 million at-the-market stock offering - Investing.com Nigeria
Elicio Therapeutics Launches New $100 Million ATM Program - TipRanks
Elicio Therapeutics Launches $100M At-The-Mar... - Benzinga
Elicio Therapeutics Launches $100 Million ATM Program With B. Riley, JonesTrading and Ladenburg - TradingView
Elicio Therapeutics (NASDAQ: ELTX) launches $100M ATM, ends prior deal - Stock Titan
Elicio Therapeutics (NASDAQ: ELTX) launches $100M ATM sales program - Stock Titan
Analysts Are Bullish on Top Healthcare Stocks: Elicio Therapeutics (ELTX), Silence Therapeutics (SLN) - The Globe and Mail
(ELTX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
H.C. Wainwright raises Elicio Therapeutics price target to $17 By Investing.com - Investing.com Canada
H.C. Wainwright raises Elicio Therapeutics price target to $17 - Investing.com
Elicio Therapeutics: Q4 Earnings Snapshot - theheraldreview.com
Elicio Therapeutics: Fourth Quarter Financial Overview - Bitget
Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates - Bitget
Elicio Therapeutics (NASDAQ: ELTX) highlights KRAS cancer vaccine and AMP platform - Stock Titan
Elicio Therapeutics 10-K: Net loss $(39.6)M, EPS $(2.58) — Y/E Dec 31, 2025 - TradingView
Elicio Therapeutics (NASDAQ: ELTX) files $400M shelf for stock, debt and warrants - Stock Titan
Elicio Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Elicio Therapeutics (Nasdaq: ELTX) narrows 2025 loss and advances ELI-002 toward Phase 3 - Stock Titan
Fewer disease progressions than projected in Elicio pancreatic trial - Stock Titan
CEO Change: Does Elicio Therapeutics Inc meet Warren Buffetts criteria2026 Big Picture & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Rodman & Renshaw initiates Elicio Therapeutics stock with buy rating By Investing.com - Investing.com South Africa
Rodman & Renshaw initiates Elicio Therapeutics stock with buy rating - Investing.com Nigeria
Whats next for Elicio Therapeutics Inc stock2026 Price Action Summary & Short-Term High Return Ideas - baoquankhu1.vn
Aug Closing: Is Elicio Therapeutics Inc a turnaround storyDay Trade & Safe Investment Capital Preservation Plans - baoquankhu1.vn
ELTX Technical Analysis & Stock Price Forecast - Intellectia AI
How (ELTX) Movements Inform Risk Allocation Models - Stock Traders Daily
Elicio Therapeutics (NASDAQ: ELTX) files S-3/A delaying effective date - Stock Titan
Elicio Therapeutics Files $400 Million Mixed Shelf - marketscreener.com
Elicio Therapeutics to issue up to $400 million in securities - marketscreener.com
Elicio Therapeutics To Issue Up To $400 Million In Securities - TradingView
Elicio Therapeutics (NASDAQ: ELTX) files $400M shelf to offer stock, debt - Stock Titan
Analyst Downgrade: Can Elicio Therapeutics Inc lead its sector in growthFed Meeting & High Accuracy Swing Trade Signals - baoquankhu1.vn
Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference - Bitget
Cancer immunotherapy firm Elicio to speak at TD Cowen health conference March 4 - Stock Titan
ELTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can Elicio Therapeutics Inc. lead its sector in growth2025 Geopolitical Influence & Verified Technical Trade Signals - mfd.ru
Why Elicio Therapeutics Inc. stock is favored by top institutionsWeekly Gains Summary & Weekly Stock Performance Updates - mfd.ru
Trading Systems Reacting to (ELTX) Volatility - Stock Traders Daily
New Elicio hire gets 30,300 options vesting over 4 years - Stock Titan
What are the future prospects of Elicio Therapeutics Inc.Stop Loss & AI Optimized Trading Strategy Guides - mfd.ru
Is Elicio Therapeutics (NASDAQ:ELTX) Using Debt In A Risky Way? - simplywall.st
How Elicio Therapeutics Inc. (ELTX) Affects Rotational Strategy Timing - Stock Traders Daily
Aug Setups: Does Elicio Therapeutics Inc offer margin of safetyNew Guidance & Smart Investment Allocation Tips - baoquankhu1.vn
(ELTX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
1.20%
0.06%
자본화:
|
볼륨(24시간):